Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sublingual Misoprostol Versus Oxytocin Titration for Induction of Labour in Parturients With Spontaneous Rupture of Fetal Membranes at Term: A Randomised Controlled Tial.

NCT06343480 is registered in ClinicalTrials.gov with Federal Teaching Hospital Abakaliki as lead sponsor.

NCT NCT06343480
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06343480 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sublingual Misoprostol Versus Oxytocin Titration for Induction of Labour in Parturients With Spontaneous Rupture of Fetal Membranes at Term: A Randomised Controlled Tial.
Lead sponsor
Federal Teaching Hospital Abakaliki
Phase
Not applicable
Overall status
Completed
Start date
September 1, 2020
Completion date
November 30, 2021
Enrollment
120 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

labor onset and length abnormalities